As with all of pharmaceutical production, the regulatory environment for the production of therapeutics has been changing as a direct result of the US FDA-initiated Quality by Design (Qb D) guidelines and corresponding activities of the International Committee for Harmonization (ICH). Given the rapid growth in the biopharmaceutical area and the comp
Buy this ebook and get 1 more FREE!
Format PDF ● Pages 327 ● ISBN 9781439829462 ● Editor Mel (University of Washington, Seattle, USA) Koch & Duncan (Amgen, Thousand Oaks, California, USA) Low ● Publisher CRC Press ● Published 2011 ● Downloadable 6 times ● Currency EUR ● ID 2382013 ● Copy protection Adobe DRM
Requires a DRM capable ebook reader